FutureFuel (FF) Q3 2025 earnings summary

Executive summary

• Revenue declined 56% year-over-year to $22.7 million for Q3 2025 and 58% to $75.9 million for the nine months ended September 30, 2025, driven by weak biofuel market conditions and plant idling.

• Net loss widened to $9.3 million for Q3 2025 and $37.4 million for the nine months, compared to net income of $1.2 million and $12.7 million in the prior-year periods.

• Adjusted EBITDA was negative $6.8 million for Q3 and negative $32.7 million for the nine months, reflecting operational challenges and lower sales.

• Strategic initiatives led to sequentially reduced net losses over the past three quarters.

Financial highlights

• Gross loss was $6.8 million for Q3 2025 and $30.2 million for the nine months, compared to gross profit of $0.4 million and $14.0 million in the prior-year periods.

• Operating expenses decreased $0.4 million in Q3 but increased $1.1 million for the nine months, mainly due to higher compensation and R&D costs.

• Cash used in operating activities was $1.3 million for the nine months, compared to $41.4 million provided in the prior year.

• Cash and cash equivalents stood at $85.6 million as of September 30, 2025, down from $109.5 million at year-end 2024.

• Capital expenditures for nine months 2025 were $14.8 million, up from $10.6 million in 2024.

Outlook and guidance

• Management expects continued uncertainty in the renewable fuel market due to pending EPA rules and evolving tax credit structures.

• Expecting to restart biodiesel production in late Q4 2025 as input costs decrease and regulatory clarity improves.

• Anticipate new chemical production ramping up in 2026 and debottlenecking projects coming online over the next few quarters.

• The company retains capacity to restart biodiesel production when market conditions improve.